JP Morgan Chase
EOLS icon

JP Morgan Chase’s Evolus EOLS Stock Holding History

JP Morgan Chase’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-110,000
Closed -$1.19M – 7480
2024
Q2 		$1.19M Buy
+110,000
New +$1.35M ﹤0.01% 4157
2020
Q2 		– Sell
-16,100
Closed -$67K – 5455
2020
Q1 		$67K Sell
16,100
-62,200
-79% -$527K ﹤0.01% 4639
2019
Q4 		$953K Buy
78,300
+18,100
+30% +$255K ﹤0.01% 3904
2019
Q3 		$940K Buy
60,200
+25,400
+73% +$416K ﹤0.01% 3871
2019
Q2 		$500K Hold
34,800
– – ﹤0.01% 4235
2019
Q1 		$785K Buy
+34,800
New +$752K ﹤0.01% 3951

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase's EOLS Position: Q1 2026 in Review

JP Morgan Chase reduced its Evolus (EOLS) stake by 86% in Q1 2026, selling an estimated $941K and leaving 31,476 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #5718.

JP Morgan Chase first reported a position in EOLS in Q1 2018 and has held it in 33 quarters since. The position peaked at $8.76M in Q1 2025. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • JP Morgan Chase held 31,476 shares of Evolus worth $124K as of Q1 2026.
  • JP Morgan Chase sold 194,126 Evolus shares in Q1 2026, an estimated $941K.
  • Evolus made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5718 holding.
  • JP Morgan Chase first reported a position in Evolus in Q1 2018 and has held it in 33 quarters since.
  • JP Morgan Chase's Evolus position peaked at $8.76M in Q1 2025.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.